Innovative solution for the bioproduction of safer active ingredients with low environmental impact.
01.
02.
03.
04.
05.
06.
Inspired by the oceans and marine microalgae, sources of life, we have created a revolutionary platform for the production of recombinant proteins. Our patented technology goes beyond the limitations of traditional methods, offering a sustainable and environmentally friendly solution.
An innovative antibody for the treatment of pediatric neuroblastoma
Our first product, an antibody for the treatment of pediatric neuroblastoma that affects 25,000 children every year. The preliminary results of our preclinical study are promising and demonstrate the functionality of this antibody produced in microalgae, opening the way to new therapeutic possibilities.
We are looking for partners to license our technology or co-develop new antibodies or recombinant proteins, and we are already preparing for the development of other antibodies to expand our range of innovative treatments (Trastuzumab, Adalimumab, Rituximab).
Boost your biotechnological projects with our custom production services. We develop cell lines to produce recombinant proteins and complex peptides in microalgae, offering innovative and ecological solutions. Our equipment, from 1L to 200L, allows a scale-up from laboratory to industrial.
Our cutting-edge technology opens up new perspectives in various sectors such as Human Health (therapeutic or diagnostic), Animal Health and Cosmetics. It makes it possible to create safer and more efficient products while meeting the growing requirements of traceability, quality and sustainability.
Human health
Cosmetic
Animal health
Resulting from 12 years of research of academic excellence, our bioproduction platform uses microalgae as a cellular factory to produce recombinant proteins. The cell lines generated are stable and robust and allow the synthesis of glycosylated proteins carrying human-like glycan structures. Thus, our technology guarantees the quality of the protein produced, the absence of viral contamination and reduces production costs by up to 70%.
Our eco-friendly technology reduces environmental impact and decarbonizes the production of recombinant proteins. It secures production, minimizes energy consumption and waste, while eliminating the use of ingredients of animal origin.
Our commitment has been recognized by several awards, including the Normandie4Good Prize, the IndoSuez Special Prize, the French Blue Tech Index, and the HealthTech Techinnov2024 Prize.
Alga Biologics collaborates with renowned academic institutions, players in the field of bioproduction and pharmaceutical companies. They have chosen to trust us, to support us and to share our values and ambitions.
